Vancheswaran Gopalakrishnan

Active 2016–2025

32
Papers
23,615
Citations
27
h-index
31
i10-index

Citations

Citations per year for Vancheswaran Gopalakrishnan1989: 1 citations2005: 2 citations2007: 4 citations2009: 1 citations2015: 2 citations2016: 5 citations2017: 81 citations2018: 265 citations2019: 932 citations2020: 1,624 citations2021: 2,028 citations2022: 1,916 citations2023: 1,653 citations2024: 2,205 citations2025: 1,421 citations2026: 59 citations1990–2004: no citations, so these years are not shown2006: no citations, so this year is not shown2008: no citations, so this year is not shown2010–2014: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,450 citing papers, 24.7% of this breakdownChina: 3,087 citing papers, 22.1% of this breakdownItaly: 626 citing papers, 4.5% of this breakdownUnited Kingdom: 593 citing papers, 4.2% of this breakdownGermany: 558 citing papers, 4% of this breakdownFrance: 544 citing papers, 3.9% of this breakdownAustralia: 434 citing papers, 3.1% of this breakdownCanada: 363 citing papers, 2.6% of this breakdownNetherlands: 356 citing papers, 2.6% of this breakdownJapan: 355 citing papers, 2.5% of this breakdownSpain: 319 citing papers, 2.3% of this breakdownSwitzerland: 246 citing papers, 1.8% of this breakdown
0%24.7%Other 21.7%

Fields

  • Medicine47.4%
  • Biochemistry, Genetics and Molecular Biology36.1%
  • Immunology and Microbiology11.4%
  • Engineering1.4%
  • Agricultural and Biological Sciences0.7%
  • Dentistry0.6%
  • Other2.4%

Topics

  • Cancer Immunotherapy and Biomarkers14%
  • Gut microbiota and health10%
  • Immunotherapy and Immune Responses5.6%
  • Immune Cell Function and Interaction4.5%
  • CAR-T cell therapy research4%
  • Immune cells in cancer3.3%
  • Other58.6%

Coauthors

All papers

Open in search
  1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pablo C. Okhuysen, V. Behrana Jensen, Alton G. Swennes, Florencia McAllister, Erick Riquelme, Yexi Zhang, Emmanuelle Le Chatelier, Laurence Zitvogel, Nicolas Pons, Jacob L. Austin-Breneman, Lauren E. Haydu, Elizabeth M. Burton, Julie M. Gardner, Elizabeth Sirmans, Jiemiao Hu, Alexander J. Lazar, Takahiro Tsujikawa, Adi Diab, Hussein A. Tawbi, Isabella C. Glitza, Wen-Jen Hwu, Sapna P. Patel, Scott E. Woodman, Rodabe N. Amaria, Michael A. Davies, Jeffrey E. Gershenwald, Patrick Hwu, J. E. Lee, J. Zhang, Lisa M. Coussens, Zachary A. Cooper, P. Andrew Futreal, Carrie R. Daniel, Nadim J. Ajami, Joseph F. Petrosino, Michael T. Tetzlaff, Padmanee Sharma, James P. Allison, Robert R. Jenq, Jennifer A. Wargo - Science 2017 cited by 4,788

  2. The human tumor microbiome is composed of tumor type–specific intracellular bacteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisa A. Rozeman, Christian U. Blank, Anat Ronai, Ron Shaoul, Amnon Amit, Tatiana Dorfman, Ran Kremer, Zvi R. Cohen, Sagi Harnof, Tali Siegal, Einav Yehuda‐Shnaidman, Einav Nili Gal‐Yam, Hagit Shapira, Nicola Baldini, Morgan G. I. Langille, Alon Ben‐Nun, Bella Kaufman, Aviram Nissan, Talia Golan, Maya Dadiani, Keren Levanon, Jair Bar, Shlomit Yust‐Katz, Iris Barshack, Daniel S. Peeper, Dan J. Raz, Eran Segal, Jennifer A. Wargo, Judith Sandbank, Noam Shental, Ravid Straussman - Science 2020 cited by 2,471

  3. B cells and tertiary lymphoid structures promote immunotherapy response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Spencer, Elizabeth M. Burton, Lauren E. Haydu, Alexander J. Lazar, Roberta Zapassodi, Courtney W. Hudgens, Deborah A. Ledesma, SuFey Ong, Michael Bailey, Sarah Warren, Disha Rao, Oscar Krijgsman, Elisa A. Rozeman, Daniel S. Peeper, Christian U. Blank, Ton N. Schumacher, Lisa H. Butterfield, Monika A. Zelazowska, Kevin M. McBride, Raghu Kalluri, James P. Allison, Florent Petitprez, Wolf H. Fridman, Catherine Sautès‐Fridman, Nir Hacohen, Katayoun Rezvani, Padmanee Sharma, Michael T. Tetzlaff, Linghua Wang, Jennifer A. Wargo - Nature 2020 cited by 2,745

  4. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen - Cell 2018 cited by 2,103

  5. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Bu, Monia Michaud, Sunia A. Trauger, Iris Barshack, Talia Golan, Judith Sandbank, Keith T. Flaherty, Anna Mandinova, Wendy S. Garrett, Sarah P. Thayer, Cristina R. Ferrone, Curtis Huttenhower, Sangeeta N. Bhatia, Dirk Gevers, Jennifer A. Wargo, Todd R. Golub, Ravid Straussman - Science 2017 cited by 1,812

  6. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mohamed A. Jamal, Erez N. Baruch, Eva Pérez‐Guijarro, Chi‐Ping Day, Glenn Merlino, Barbara Pazdrak, Brooke S. Lochmann, Robert Szczepaniak‐Sloane, Reetakshi Arora, Jaime Anderson, Chrystia M. Zobniw, Eliza Posada, Elizabeth Sirmans, Julie M. Simon, Lauren E. Haydu, Elizabeth M. Burton, Linghua Wang, Minghao Dang, Karen Clise-Dwyer, Sarah Schneider, Thomas Chapman, Nana-Ama A.S. Anang, Sheila Duncan, Joseph Toker, Jared Malke, Isabella C. Glitza, Rodabe N. Amaria, Hussein A. Tawbi, Adi Diab, Michael K. Wong, Sapna P. Patel, Scott E. Woodman, Michael A. Davies, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, V. Behrana Jensen, Yardena Samuels, Ravid Straussman, Nadim J. Ajami, Kelly C. Nelson, Luigi Nezi, Joseph F. Petrosino, P. Andrew Futreal, Alexander J. Lazar, Jianhua Hu, Robert R. Jenq, Michael T. Tetzlaff, Yan Yan, Wendy S. Garrett, Curtis Huttenhower, Padmanee Sharma, Stephanie S. Watowich, James P. Allison, Lorenzo Cohen, Giorgio Trinchieri, Carrie R. Daniel, Jennifer A. Wargo - Science 2021 cited by 932

  7. The microbiome, cancer, and cancer therapy

    Authors: , , , , - Nature Medicine 2019 cited by 1,220

  8. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

    Authors: , , , , - Cancer Cell 2018 cited by 1,363

  9. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 721

  10. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Khalida Wani, Alexander J. Lazar, Michael T. Tetzlaff, Courtney W. Hudgens, Margaret K. Callahan, Matthew Adamow, Michael A. Postow, Charlotte E. Ariyan, Pierre-Olivier Gaudreau, Luigi Nezi, Didier Raoult, Catalin Mihalcioiu, Arielle Elkrief, Rossanna C. Pezo, Lauren E. Haydu, Julie M. Simon, Hussein A. Tawbi, Jennifer L. McQuade, Patrick Hwu, Wen-Jen Hwu, Rodabe N. Amaria, Elizabeth M. Burton, Scott E. Woodman, Stephanie S. Watowich, Adi Diab, Sapna P. Patel, Isabella C. Glitza, Michael K.K. Wong, Li Zhao, Jianhua Zhang, Nadim J. Ajami, Joseph F. Petrosino, Robert R. Jenq, Michael A. Davies, Jeffrey E. Gershenwald, P. Andrew Futreal, Padmanee Sharma, James P. Allison, Bertrand Routy, Laurence Zitvogel, Jennifer A. Wargo - Nature Medicine 2021 cited by 415

  11. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rodabe N. Amaria, Lawrence N. Kwong, Víctor G. Prieto, R. Eric Davis, Wencai Ma, Willem W. Overwijk, Arlene H. Sharpe, Jianhua Hu, P. Andrew Futreal, Jorge Blando, Padmanee Sharma, James P. Allison, Lynda Chin, Jennifer A. Wargo - Cancer Discovery 2016 cited by 1,008

  12. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liberty Posada, Lauren E. Haydu, Linghua Wang, Shaojun Zhang, Alexander J. Lazar, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Alexandre Reuben, Miles C. Andrews, Christine N. Spencer, Víctor G. Prieto, Padmanee Sharma, James P. Allison, Michael T. Tetzlaff, Jennifer A. Wargo - Nature Medicine 2018 cited by 826

  13. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott E. Woodman, Rodabe N. Amaria, Víctor G. Prieto, Jianhua Hu, Padmanee Sharma, James P. Allison, Lynda Chin, Jianhua Zhang, Jennifer A. Wargo, P. Andrew Futreal - Science Translational Medicine 2017 cited by 920

  14. The gut microbiota influences anticancer immunosurveillance and general health

    Authors: , , , , , - Nature Reviews Clinical Oncology 2018 cited by 504

  15. Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 cited by 117

  16. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charl Verwey, Mark T. Esser, David E. Tabor, Louis Bont, Pascale Marro Clément, Atul Gupta, Koichi Hashimoto, Kseniya Komissarova, Matt Laubscher, Magali Santos Lumertz, Elena Priante, Irene Rivero‐Calle, Ushma Wadia, Ki Wook Yun - The Lancet Infectious Diseases 2023 cited by 105

  17. Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincenzo Bronte, Jennifer A. Wargo, Laurence Zitvogel - Cell Research 2019 cited by 248

  18. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy

    Authors: , , , , - Trends in Immunology 2018 cited by 97

  19. Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , - Clinical Infectious Diseases 2019 cited by 133

  20. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth M. Burton, Sangeetha M. Reddy, Padmanee Sharma, James P. Allison, Phillip Andrew Futreal, Scott E. Woodman, Michael A. Davies, Jennifer A. Wargo - The Lancet Oncology 2018 cited by 290

  21. Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)

    Authors: , , , , , , , , , , , , , , , , , , , , - Neoplasia 2022 cited by 51

  22. TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William N. William, Stephen G. Swisher, John V. Heymach, Harlan Robins, J. Jack Lee, Padmanee Sharma, James P. Allison, P. Andrew Futreal, Ignacio I. Wistuba, Jianjun Zhang - Cancer Discovery 2017 cited by 236

  23. Engraftment of Bacteria after Fecal Microbiota Transplantation Is Dependent on Both Frequency of Dosing and Duration of Preparative Antibiotic Regimen

    Authors: , , , , , , , , , , - Microorganisms 2021 cited by 40

  24. Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2019 cited by 104